# Paclitaxel in Treating Patients With Ovarian Stromal Cancer

> **NCT00006227** · PHASE2 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 31 (actual)

## Conditions studied

- Adult Type Ovarian Granulosa Cell Tumor
- Ovarian Gynandroblastoma
- Ovarian Sertoli-Leydig Cell Tumor
- Ovarian Sex Cord Tumor With Annular Tubules
- Ovarian Steroid Cell Tumor

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00006227
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11-20
- **Primary completion:** 2016-07-16
- **Final completion:** 2016-07-16
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006227, "Paclitaxel in Treating Patients With Ovarian Stromal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*